11/12/24 19:29 | 11/8/24 | AUPH | Aurinia Pharmaceuticals Inc. | | Health | Drug | Pharmaceutical Preparations | Bailey Jeffrey Allen | A0 | D | | M.d | 0 | 0.00 | 0 | 18 | | 13 | D | | | | | | | | | | | | | | |
11/12/24 19:29 | 11/11/24 | AUPH | Aurinia Pharmaceuticals Inc. | | Health | Drug | Pharmaceutical Preparations | Bailey Jeffrey Allen | A0 | D | | S.d | -38 | 8.43 | 0 | -5 | -25 | 13 | D | | | | | | | | | | | | | | |
3/11/22 08:08 | 3/9/22 | BDSI | Biodelivery Sciences International Inc | DE | Health | Drug | Pharmaceutical Preparations | Bailey Jeffrey Allen | NC | DO | CEO | M.d | 0 | 0.00 | 0 | 5 | 5 | 105 | D | | | | | | | | | | | | | | |
11/8/21 16:40 | 11/4/21 | BDSI | Biodelivery Sciences International Inc | DE | Health | Drug | Pharmaceutical Preparations | Bailey Jeffrey Allen | NC | DO | CEO | M.d | 0 | 0.00 | 0 | 53 | 115 | 100 | D | | | | | | | | | | | | | | |
8/10/21 18:23 | 8/6/21 | BDSI | Biodelivery Sciences International Inc | DE | Health | Drug | Pharmaceutical Preparations | Bailey Jeffrey Allen | NC | DO | CEO | M.d | 0 | 0.00 | 0 | 6 | 14 | 46 | D | | | | | | | | | | | | | | |
3/11/21 16:14 | 3/9/21 | BDSI | Biodelivery Sciences International Inc | DE | Health | Drug | Pharmaceutical Preparations | Bailey Jeffrey Allen | NC | DO | CEO | M.d | 0 | 0.00 | 0 | 5 | 15 | 41 | D | | | | | | | | | | | | | | |
12/16/20 16:41 | 12/15/20 | BDSI | Biodelivery Sciences International Inc | DE | Health | Drug | Pharmaceutical Preparations | Bailey Jeffrey Allen | NC | DO | CEO | S | -44 | 4.35 | 0 | -10 | -22 | 36 | D | | | | | | | | | | | | | | |
11/6/20 17:21 | 11/4/20 | BDSI | Biodelivery Sciences International Inc | DE | Health | Drug | Pharmaceutical Preparations | Bailey Jeffrey Allen | NC | DO | CEO | M.d | 0 | 0.00 | 0 | 40 | 719 | 46 | D | | | | | | | | | | | | | | |
9/23/20 15:57 | 9/23/20 | THW | Tekla World Healthcare Fund | | Fund | CEF | Closed-End Funds | Bailey Jeffrey Allen | MA | D | | P | 10 | 14.18 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
9/23/20 15:57 | 9/23/20 | THQ | Tekla Healthcare Opportunities Fund | | Fund | CEF | Closed-End Funds | Bailey Jeffrey Allen | MA | D | | P | 10 | 17.68 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
9/23/20 15:56 | 9/23/20 | HQH | Tekla Healthcare Investors | MA | Fund | CEF | Closed-End Funds | Bailey Jeffrey Allen | MA | D | | P | 10 | 20.39 | 0 | 0 | New | 0 | D | | | | | | | | | | | | | | |
9/23/20 15:56 | 9/22/20 | HQL | Tekla Life Sciences Investors | MA | Fund | CEF | Closed-End Funds | Bailey Jeffrey Allen | MA | D | | P | 10 | 17.28 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
8/11/20 16:53 | 8/7/20 | BDSI | Biodelivery Sciences International Inc | DE | Health | Drug | Pharmaceutical Preparations | Bailey Jeffrey Allen | NC | DO | CEO | M.d | 0 | 0.00 | 0 | 6 | New | 6 | D | | | | | | | | | | | | | | |
11/18/19 16:15 | 11/14/19 | ALRN | Aileron Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Bailey Jeffrey Allen | MA | D | | P.m | 28 | 0.5100 | 0 | 55 | 276 | 75 | D | | | | | | | | | | | | | | |
11/14/19 16:23 | 11/12/19 | ALRN | Aileron Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Bailey Jeffrey Allen | MA | D | | P | 11 | 0.5300 | 0 | 20 | New | 20 | D | | | | | | | | | | | | | | |